Advances in Proteomics of Mycobacterium leprae

Scandinavian Journal of Immunology

Volumn 75, Issue 4, 2012, Pages 369-378

  Parkash, O ^a   Singh, B P ^b  

^a NATIONAL JALMA INSTITUTE FOR LEPROSY AND OTHER MYCOBACTERIAL DISEASES   (India)

^b DUPONT COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN;

AMINO ACID SEQUENCE; CELL FRACTIONATION; ELECTROBLOTTING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MYCOBACTERIUM LEPRAE; NONHUMAN; PATHOGENESIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PURIFICATION; PROTEIN TARGETING; PROTEOMICS; REVIEW; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALS; BACTERIAL PROTEINS; HUMANS; LEPROSY; MYCOBACTERIUM LEPRAE; PROTEOME; PROTEOMICS;

EID: 84858595218     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2012.02677.x     Document Type: Review

References (79)

1. World Health Organization. Global leprosy situation, 2010. Wkly Epidemiol Rec 2010;85:337-48.
2. Geluk A, Klein MR, Franken KL et al. Postgenomic approach to identify novel Mycobacterium leprae antigens with potential to improve immunodiagnosis of infection. Infect Immun 2005;73:5636-44.
3. Spencer JS, Dockrell HM, Kim HJ et al. Identification of specific proteins and peptides in Mycobacterium leprae suitable for the selective diagnosis of leprosy. J Immunol 2005;175:7930-8.
4. Reece ST, Ireton G, Mohamath R et al. ML0405 and ML2331 are antigens of Mycobacterium leprae with potential for diagnosis of leprosy. Clin Vaccine Immunol 2006;13:333-40.
5. Groathouse NA, Amin A, Marques MA et al. Use of protein microarrays to define the humoral immune response in leprosy patients and identification of disease-state-specific antigenic profiles. Infect Immun 2006;74:6458-66.
6. Duthie MS, Goto W, Ireton GC et al. Use of protein antigens for early serological diagnosis of leprosy. Clin Vaccine Immunol 2007;14:1400-8.
7. Duthie MS, Ireton GC, Kanaujia GV et al. Selection of antigens and development of prototype tests for point-of-care leprosy diagnosis. Clin Vaccine Immunol 2008;15:1590-7.
8. Duthie MS, Goto W, Ireton GC et al. Antigen-specific T-cell responses of leprosy patients. Clin Vaccine Immunol 2008;15:1659-65.
9. Geluk A, Spencer JS, Bobosha K et al. From genome-based in silico predictions to ex vivo verification of leprosy diagnosis. Clin Vaccine Immunol 2009;16:352-9.
10. Spencer JS, Kim HJ, Wheat WH et al. Analysis of antibody responses to Mycobacterium leprae phenolic glycolipid I, lipoarabinomannan, and recombinant proteins to define disease subtype-specific antigenic profiles in leprosy. Clin Vaccine Immunol 2011;18:260-7.
11. Duthie MS, Hay MN, Morales CZ et al. Rational design and evaluation of a multiepitope chimeric fusion protein with the potential for leprosy diagnosis. Clin Vaccine Immunol 2010;17:298-303.
12. Pessolani MC, Brennan PJ. Molecular definition and identification of new proteins of Mycobacterium leprae. Infect Immun 1996;64:5425-7.
13. Marques MA, Chitale S, Brennan PJ, Pessolani MC. Mapping and identification of the major cell wall-associated components of Mycobacterium leprae. Infect Immun 1998;66:2625-31.
14. Marques MAM, Espinosa BJ, da Silveira EKX et al. Continued proteomic analysis of Mycobacterium leprae subcellular fractions. Proteomics 2004;4:2942-53.
15. Marques MAM, Neves-Ferreira AG, da Silveira EK et al. Deciphering the proteomic profile of M. leprae cell envelope. Proteomics 2008;8:2477-91.
16. de Souza GA, Søfteland T, Koehler CJ, Thiede B, Wiker HG. Validating divergent ORF annotation of the Mycobacterium leprae genome through a full translation data set and peptide identification by tandem mass spectrometry. Proteomics 2009;9:3233-43.
17. Wiker HG, Tomazella GG, de Souza GA. A quantitative view on Mycobacterium leprae antigens by proteomics. J Proteomics 2011;74:1711-9.
18. Truman R, Sanchez R. Armadillos: models for leprosy. Lab Anim 1993;22:28-32.
19. Scollard DM, Adams LB, Gillis TP et al. The continuing challenges of leprosy. Clin Microbiol Rev 2006;19:338-81.
20. Cole ST, Eiglmeier K, Parkhill J et al. Massive gene decay in the leprosy bacillus. Nature 2001;409:1007-11.
21. Monot M, Honoré N, Garnier T et al. Comparative genomic and phylogeographic analysis of Mycobacterium leprae. Nat Genet 2009;41:1282-9.
22. Gomez-Valero L, Rocha EP, Latorre A, Silva FJ. Reconstructing the ancestor of Mycobacterium leprae: the dynamics of gene loss and genome reduction. Genome Res 2007;17:1178-85.
23. Eiglmeier K, Parkhill J, Honore N et al. The decaying genome of Mycobacterium leprae. Lepr Rev 2001;72:387-98.
24. Eiglmeier K, Simon S, Garnier T, Cole ST. The integrated genome map of Mycobacterium leprae. Lepr Rev 2001;72:462-9.
25. Singh P, Cole ST. Mycobacterium leprae: genes, pseudogenes and genetic diversity. Future Microbiol 2011;6:57-71.
26. Araoz R, Honore N, Cho S et al. Antigen discovery: a postgenomic approach to leprosy diagnosis. Infect Immun 2006;74:175-82.
27. Geluk A, Klein MR, Franken KL et al. Postgenomic approach to identify novel Mycobacterium leprae antigens with potential to improve immunodiagnosis of infection. Infect Immun 2005;73:5636-44.
28. Marri PR, Bannantine JP, Golding GB. Comparative genomics of metabolic pathways in Mycobacterium species: gene duplication, gene decay and lateral gene transfer. FEMS Microbiol Rev 2006;30:906-25.
29. Wasinger VC, Cordwell SJ, Cerpa-Poljak A et al. Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium. Electrophoresis 1995;16:1090-4.
30. James P. Protein identification in the post-genome era: the rapid rise of proteomics. Q Rev Biophys 1997;30:279-331.
31. Melsom R. Serodiagnosis of leprosy: the past, the present, and some prospects for the future. Int J Lepr Other Mycobact Dis 1983;51:235-52.
32. Gaylord H, Brennan PJ. Leprosy and the leprosy bacillus: recent developments in characterization of antigens and immunology of the disease. Annu Rev Microbiol 1987;41:645-75.
33. Young D, Lathigra R, Hendrix R, Sweetser D, Young RA. Stress proteins are immune targets in leprosy and tuberculosis. Proc Natl Acad Sci USA 1988;85:4267-70.
34. Booth RJ, Harris DP, Love JM, Watson JD. Antigenic proteins of Mycobacterium leprae. Complete sequence of the gene for the 18-kDa protein. J Immunol 1988;140:597-601.
35. Thangaraj HS, Lamb FI, Davis EO et al. Identification, sequencing, and expression of Mycobacterium leprae superoxide dismutase, a major antigen. Infect Immun 1990;58:1937-42.
36. Hunter SW, Rivoire B, Mehra V, Bloom BR, Brennan PJ. The major native proteins of the leprosy bacillus. J Biol Chem 1990;265:14065-8.
37. Rivoire B, Pessolani MC, Bozic CM et al., Brennan PJ Chemical definition, cloning, and expression of the major protein of the leprosy bacillus. Infect Immun 1994;62:2417-25.
38. Pessolani MC, Smith DR, Rivoire B et al. Purification, characterization, gene sequence, and significance of a bacterioferritin from Mycobacterium leprae. J Exp Med 1994;180:319-27.
39. Thole JER, Wiells B, Clark-Curtiss JRE, Ottenhoff THM, Rinke de Wit TF. Immunological and functional characterization of Mycobacterium leprae protein antigen: an overview. Mol Microbiol 1995;18:791-800.
40. Chakrabarty AK, Maire MA, Lambert PH. SDS-PAGE analysis of M. leprae protein antigens reacting with antibodies from sera from lepromatous patients and infected armadillos. Clin Exp Immunol 1982;49:523-31.
41. Klatser PR, van Rens MM, Eggelte TA. Immunochemical characterization of Mycobacterium leprae antigens by the SDS-polyacrylamide gel electrophoresis immunoperoxidase technique (SGIP) using patients' sera. Clin Exp Immunol 1984;56:537-44.
42. Wang Y, Al-Gazzar A, Seibert C et al. Proteomic analysis of cytochromes P450: a mass spectrometry approach. Biochem Soc Trans 2006;34:1246-51.
43. Supek F, Peharec P, Krsnik-Rasol M, Smuc T. Enhanced analytical power of SDS-PAGE using machine learning algorithms. Proteomics 2008;8:28-31.
44. Gygi SP, Corthals GL, Zhang Y, Rochon Y, Aebersold R. Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc Natl Acad Sci USA 2000;97:9390-5.
45. Görg A, Weiss W, Dunn MJ. Current two-dimensional electrophoresis technology for proteomics. Proteomics 2004;4:3665-85.
46. Corthals GL, Wasinger VC, Hochstrasser DF, Sanchez JC. The dynamic range of protein expression: a challenge for proteomic research. Electrophoresis 2000;21:1104-15.
47. Luque-Garcia JL, Zhou G, Spellman DS, Sun TT, Neubert TA. Analysis of electroblotted proteins by mass spectrometry: protein identification after Western blotting. Mol Cell Proteomics 2008;7:308-14.
48. Komatsu S. Edman sequencing of proteins from 2D gels. Methods Mol Biol 2007;355:211-7.
49. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Biotechnology 1992;24:145-9.
50. Neverova I, Van Eyk JE. Role of chromatographic techniques in proteomic analysis. J. Chromatogr B Analyt Technol Biomed Life Sci 2005;815:51-63.
51. Edman P. A method for the determination of the amino acid sequence of peptides. Arch Biochem Biophys 1949;22:475-6.
52. Miyashita M, Presley JM, Buchholz BA et al. Attomole level protein sequencing by Edman degradation coupled with accelerator mass spectrometry. Proc Natl Acad Sci U S A 2001;98:4403-8.
53. Aebersold R, Goodlett DR. Mass spectrometry in proteomics. Chem Rev 2001;101:269-95.
54. Jimmmy KE, Ashley LM, John RY. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass Spectrom 1994;5:976-89.
55. Diament BJ, Noble WS. Faster SEQUEST Searching for Peptide Identification from Tandem Mass Spectra. J Proteome Res 2011;10:3871-9.
56. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999;20:3551-67.
57. Koenig T, Menze BH, Kirchner M et al. Robust prediction of the MASCOT score for an improved quality assessment in mass spectrometric proteomics. J Proteome Res 2008;7:3708-17.
58. Keller A, Eng J, Zhang N, Li XJ, Aebersold R. A Uniform proteomics MS/MS analysis platform utilizing open XML file formats. Mol Syst Biol 2005;1:2005.0017.
59. Craig R, Beavis RC. TANDEM: matching proteins with tandem mass spectra. Bioinformatics 2004;20:1466-7.
60. Bjornson RD, Carriero NJ, Colangelo C et al. X!!Tandem, an improved method for running X!tandem in parallel on collections of commodity computers. J Proteome Res 2008;7:293-9.
61. World Health Organization. Purification of Mycobacterium leprae. Annex 4 of report of the Fifth Meeting of the Scientific Working Group on the Immunology of Leprosy (IMMLEP), Geneva, 24-26 June 1980. World Health Organization document TDR/IMMLEP-SWG(5)/80.3. World Health Organization, Geneva.
62. Pessolani MCV, Brennan PJ. Mycobacterium leprae produces extracellular homologs of the antigen 85 complex. Infect Immun 1992;60:4452-9.
63. Via LE, Curcic R, Mudd MH, Dhandayuthapani S, Ulmer RJ, Deretic V. Elements of signal transduction in Mycobacterium tuberculosis: in vitro phosphorylation and in vivo expression of the response regulator MtrA. J Bacteriol 1996;178:3314-21.
64. Zahrt TC, Deretic V. An essential two-component signal transduction system in Mycobacterium tuberculosis. J Bacteriol 2000;182:3832-8.
65. Sela S, Thole JE, Ottenhoff TH, Clark-Curtiss JE. Identification of Mycobacterium leprae antigens from a cosmid library: characterization of a 15-kilodalton antigen that is recognized by both the humoral and cellular immune systems in leprosy patients. Infect Immun 1991;59:4117-24.
66. Goosen N, van de Putte P. The regulation of transcription initiation by integration host factor. Mol Microbiol 1995;16:1-7.
67. Jacobson GR, Rosenbusch JP. Abundance and membrane association of elongation factor Tu in E. coli. Nature 1976;261:23-6.
68. Landini P, Bandera M, Goldstein BP et al. Inhibition of bacterial protein synthesis by elongation-factor-Tu-binding antibiotics MDL 62, 879 and efrotomycin. Biochem J 1992;283:649-52.
69. Closs O, Mshana RN, Harboe M. Antigenic analysis of Mycobacterium leprae. Scand J Immunol 1979;9:297-302.
70. Sinha S, Sengupta U, Ramu G, Ivanyi J. A serological test for leprosy based on competitive inhibition of monoclonal antibody binding to the MY2a determinant of M. leprae. Trans Roy Soc Trop Med Hyg 1983;77:869-71.
71. Parkash O. Antibody based assays to detect M. leprae infection: towards a new horizon. J Immunol Immunopathol 2006;8:10-4.
72. Parkash O, Kumar A, Nigam A, Franken KL, Ottenhoff TH. Evaluation of recombinant serine-rich 45-kDa antigen (ML0411) for detection of antibodies in leprosy patients. Scand J Immunol 2006;64:450-5.
73. Parkash O, Kumar A, Nigam A, Girdhar BK. Detection of antibodies against M. leprae culture filtrate protein-10 in leprosy patients. J Med Microbiol 2006;55:1337-41.
74. Parkash O, Pandey R, Kumar A, Kumar A. Performance of recombinant ESAT-6 antigen (ML0049) for detection of leprosy patients. Lett Appl Microbiol 2007;44:524-30.
75. Maeda Y, Mukai T, Kai M. Evaluation of major membrane protein-II as a tool for serodiagnosis of leprosy. FEMS Microbiol Lett 2007;272:202-5.
76. Araoz R, Honore N, Banu S et al. Towards an immunodiagnostic test for leprosy. Microbes Infect 2006;8:2270-6.
77. Spencer JS, Kim HJ, Marques AM et al. Comparative analysis of B- and T-cell epitopes of Mycobacterium leprae and Mycobacterium tuberculosis culture filtrate protein 10. Infect Immun 2004;72:3161-70.
78. Sampaio LH, Stefani MM, Oliveira RM et al. Immunologically reactive M. leprae antigens with relevance to diagnosis and vaccine development. BMC Infect Dis 2011;11:2-11.
79. Kumar A, Girdhar BK, Parkash O. Immunoproteomic analysis of Mycobacterium leprae derived cell membrane antigens. Int J Biol Med Res 2010;1:242-7.